BusinessGeneral NewsIndustryInternationalUncategorized

Global Sarcopenia Treatment Market to Reflect Steady Growth Rate by 2026 Data Bridge Market Research Report | Key Players – Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone, Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd

The Global Sarcopenia Treatment Market research report is a highly informative report in which inside-out investigation of the Global Sarcopenia Treatment Market has been carried out to accomplish benefits. The report examines the forthcoming patterns alongside difficulties and openings in the Pharmaceutical industry. The report similarly fuses the market drivers and market limitations that are gotten from SWOT examination. This factual reviewing report offers a far reaching investigation of product detail, development, product type, market patterns, market size, and so forth. It grandstands all the progressing upgrades, product dispatches, joint undertakings, mergers and acquisitions by the few key players and brands that are driving the market.

Key Global Sarcopenia Treatment Market Players:

Few of the major competitors currently working in the global sarcopenia treatment market are Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone, Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Nestlé, Mitacs, Sanofi, Bayer AG, Amway, Zydus Cadila, Eli Lilly and Company, Radius Health, Inc., MYSURABLE S.R.L., PhaseBio Pharmaceuticals, Inc among others.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sarcopenia-treatment-market

Global Sarcopenia Treatment Market By Treatment Type (Medication, Vitamin/Dietary Supplements and Others), Route of Administration (Oral, Injectable and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Global Sarcopenia Treatment Market Analysis

Global Sarcopenia treatment market is rising gradually with a steady CAGR in the forecast period of 2019-2026. The growing prevalence of sarcopenia by increasing old age population and adoption of sedentary and unhealthy lifestyle is the major factor that contributes in the growth of global sarcopenia treatment market.

Global Sarcopenia Treatment Market Definition

Sarcopenia is a progressive skeletal muscle disorder. It involves the loss of muscle mass and strength due to natural aging process. This condition affects the gait and overall ability of body to perform normal tasks. According to International Osteoporosis Foundation (IOF), the muscle loss starts from the age of 40. The major causes of sarcopenia could be sedentary lifestyle, malnutrition and unhealthy food intake. The increasing population of people aged more than 60 and the increasing cases of malnutrition worldwide are the major factors augmenting the market growth.

Market Drivers

  •  Prevelance of geriatric population is expected to boost the market growth
  • Increasing adoption of vitamins and dietary supplements among the ageing population for better treatment of this disorder also acts as a market driver The prevalence of sarcopenia is high among old age population drives the global sarcopenia treatment market
  • Surging research and development activities for the treatment of sarcopenia also acts as a driver for this market
  • Rising cases of malnutrition due to poor nutritional intake can also augment the growth of this market

Market Restraints

  • Lack of awareness among people regarding the muscle loss can act as a major restraint for this market
  • Lack of skilled medical profession for the diagnosis of this disorder is also less; this factor can also restrict the growth of this market
  • High cost of protein supplement and unavailability of sarcopenia treatment drugs can also impede the market growth

Ask an Analyst @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-sarcopenia-treatment-market

Segmentation: Global Sarcopenia Treatment Market

By Treatment

  • Medication
  • Vitamin/ Dietary Supplements
  • Others

By Route of Administration

  • Oral
  • Injectable

 By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-sarcopenia-treatment-market

Key Developments in the Market:

  • In April 2019. MYSURABLE S.R.L., has developed mioTest, a system based on effective and scientifically validated tools that identifies the risk of sarcopenia. The system can also assess muscle mass composition including functionality and level of hydration of muscles in a beneficial and non-invasive way
  • In April 2019, PhaseBio Pharmaceuticals, Inc. licensed ImmunoForge, Co. Ltd. the global rights for PB1023, a recombinant GLP-1 analogue used for the treatment of patients with sarcopenia. ImmunoForge, Co. Ltd. is working on a pipeline for development of novel therapies for sarcopenia related diseases. PhaseBio Pharmaceuticals, Inc. will receive development milestone payments and royalty payments on the sales of the product by this licensed agreement

Competitive Analysis:

Global sarcopenia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sarcopenia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global sarcopenia treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Want Full Report? Enquire Here: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-sarcopenia-treatment-market

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]
https://databridgemarketresearch.com

Report Rating
Close